• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chemours Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/6/25 4:32:17 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email
    8-K
    false000162722300016272232025-05-062025-05-06

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    May 6, 2025

    Date of Report (Date of Earliest Event Reported)

    img173608473_0.jpg

    The Chemours Company

    (Exact Name of Registrant as Specified in Its Charter)

     

    Delaware

     

    001-36794

     

    46-4845564

    (State or Other Jurisdiction

     

    (Commission

     

    (I.R.S. Employer

    Of Incorporation)

     

    File Number)

     

    Identification No.)

     

    1007 Market Street

    Wilmington, Delaware 19801

    (Address of principal executive offices)

     

    Registrant’s telephone number, including area code: (302) 773-1000

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading Symbol(s)

     

    Name of Exchange on Which Registered

    Common Stock ($0.01 par value)

     

    CC

     

    New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company

     

    ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

     

    ☐

     

     

     


    Item 2.02 Results of Operations and Financial Condition.

     

    On May 6, 2025, The Chemours Company (the “Company”) issued a press release regarding its first quarter 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025, for its conference call scheduled for that time.

     

    The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

    99.1 Press release dated May 6, 2025.

    104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

     

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    THE CHEMOURS COMPANY

     

    By:

     

    /s/ Shane Hostetter

     

     

    Shane Hostetter

     

     

    Senior Vice President, Chief Financial Officer

    Date:

     

    May 6, 2025

     

     

     


    Get the next $CC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture

      Partnership to establish initial capacity & enable adoption of Opteon™ two-phase immersion cooling fluid to address data center cooling needs created by AI and next-generation chips The Chemours Company (Chemours) (NYSE:CC), a global chemistry company, announced a strategic agreement with Navin Fluorine International Limited (Navin Fluorine) (NSE: NAVINFLUOR) to manufacture its Opteon™ two-phase immersion cooling fluid. The collaboration is part of Chemours' expanded Liquid Cooling Venture, established to address the growing heat, energy, and water demands of advanced data centers and AI hardware. The partnership with Navin Fluorine marks an important step toward commercialization, providi

      5/6/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

      4/16/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

      GREENWICH, Conn., March 18, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025.  The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment.  Attendees will also have the opportunity to meet with managements in a one-on-one setting. Agenda: 8:50amOpening Remarks Rosemarie Morbelli, CFA Gabelli Funds   Wayne Pinsent, CFA Gabelli Funds    9:00Arq, Inc. (NASDAQ:ARQ)* Bob Rasmus, President & CEO        9:30BASF Corporation

      3/18/25 8:00:00 AM ET
      $ARQ
      $AVD
      $CC
      $GGZ
      Major Chemicals
      Industrials
      Agricultural Chemicals
      Investment Managers

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chemours Company

      SC 13G/A - Chemours Co (0001627223) (Subject)

      11/12/24 9:55:16 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      2/9/24 8:50:19 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      1/24/24 9:46:44 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Financials

    Live finance-specific insights

    See more
    • Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

      4/16/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces First Quarter Dividend

      The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut

      2/14/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (

      2/3/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    SEC Filings

    See more
    • SEC Form 10-Q filed by Chemours Company

      10-Q - Chemours Co (0001627223) (Filer)

      5/6/25 4:35:35 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Chemours Co (0001627223) (Filer)

      5/6/25 4:32:17 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Chemours Co (0001627223) (Filer)

      4/24/25 4:36:30 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cowan Alister was granted 14,096 shares, increasing direct ownership by 65% to 35,831 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:36:51 PM ET
      $CC
      Major Chemicals
      Industrials
    • Director Farrell Dawn L was granted 14,096 shares, increasing direct ownership by 17% to 97,636 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:35:52 PM ET
      $CC
      Major Chemicals
      Industrials
    • Director Fletcher Pamela was granted 14,096 shares, increasing direct ownership by 135% to 24,565 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:34:51 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chemours upgraded by Mizuho with a new price target

      Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

      3/27/25 8:05:02 AM ET
      $CC
      Major Chemicals
      Industrials
    • Truist initiated coverage on Chemours with a new price target

      Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

      1/28/25 7:09:50 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours upgraded by UBS with a new price target

      UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

      7/9/24 8:13:51 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    See more
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance
    • Chemours Appoints Leslie M. Turner to its Board of Directors

      Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours' Board of Directors The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211667601/en/Chemours appoints Leslie M. Turner to its Board

      2/11/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Damián Gumpel as President of Titanium Technologies and Diane Picho as Chief Enterprise Enablement Officer

      The Chemours Company (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours' Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho

      1/17/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials